On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like Is Yum Brands Starting to Look Tasty? | YUM September 26, 2026 Kraft Heinz (KHC) April 21, 2021 Gen Digital Inc.: GEN June 6, 2023
You Might Also Like Is Yum Brands Starting to Look Tasty? | YUM September 26, 2026 Kraft Heinz (KHC) April 21, 2021 Gen Digital Inc.: GEN June 6, 2023
